A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T Cells Incorporating a Chlorotoxin Tumor-targeting Domain for Patients with MMP2+ Recurrent or Progressive Glioblastoma

Click on the icons below to download preferred medium
MP4
15MB
PowerPoint
3.5 MB
PDF
0.5 MB

 

Share on facebook
Share on twitter
Share on linkedin